Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
VALERITAS Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 309,85 | +1,51 % | UnitedHealth auf Erholungskurs: Hatte Buffett den richtigen Riecher? | In den zurückliegenden Handelswochen hat sich die Aktie des größten US-Krankenversicherers von den Tiefständen lösen können. Der Einstieg von Investmentlegende Warren Buffett mit seiner Beteiligungsgesellschaft... ► Artikel lesen | |
TELADOC HEALTH | 7,106 | +2,96 % | 780 % Rendite dank teurer Medizin: PanGenomic Health, CVS Health, Teladoc Health | Die Kosten im Gesundheitswesen explodieren. Wie KFF, eine führende gesundheitspolitische Organisation der USA schreibt, gaben die Vereinigten Staaten bereits 2022 rund 4,5 Billionen USD für Gesundheit... ► Artikel lesen | |
THERMO FISHER | 453,95 | +0,43 % | What to Expect From Thermo Fisher's Q3 2025 Earnings Report | ||
ROKU | 80,86 | +1,85 % | The Roku Streaming Stick Plus was one of my Prime Day favorites - and it's still on sale | ||
RESMED | 236,10 | +0,81 % | Fractus files patent infringement complaint against ResMed in the Southern District of California | Action seeks to protect Fractus' pioneering antenna inventions used in connected sleep apnea therapies/devices
BARCELONA, Spain, Oct. 13, 2025 /PRNewswire/ -- Fractus... ► Artikel lesen | |
HENRY SCHEIN | 54,98 | +1,03 % | Henry Schein Inc. Q2 Profit Decreases, Misses Estimates | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced earnings for second quarter that Decreased from the same period last year and missed the Street estimates.The company's bottom line came... ► Artikel lesen | |
ZIMMER BIOMET | 82,60 | +1,25 % | Zimmer Biomet stärkt Robotik-Geschäft mit Übernahme von Monogram Technologies | Zimmer Biomet Holdings hat die Übernahme des Medizintechnikunternehmens Monogram Technologies abgeschlossen. Der US-Konzern erweitert damit sein Angebot im Bereich orthopädischer Robotik um eine weitere... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA | BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized... ► Artikel lesen | |
PETMED EXPRESS | 2,070 | -1,29 % | PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
TANDEM DIABETES | 12,100 | +0,37 % | Tandem Diabetes To Pay Roche $36 Mln To Settle Patent Infringement Claim | SOUTH SAN FRANCISCO (dpa-AFX) - Tandem Diabetes Care, Inc. has agreed to pay Roche Holding $36 million over a five year period to settle a patent infringement claim.On May 21, Tandem Diabetes... ► Artikel lesen | |
QUIDELORTHO | 23,600 | +3,51 % | QuidelOrtho Corporation: QuidelOrtho Completes Debt Refinancing | SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic... ► Artikel lesen | |
VERU | 4,070 | +4,09 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
QUEST DIAGNOSTICS | 158,00 | -0,35 % | What to Expect From Quest Diagnostics' Next Quarterly Earnings Report | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
SENSEONICS | 0,350 | -3,42 % | Senseonics Holdings, Inc.: Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update | Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October... ► Artikel lesen |